Hello, everyone, and how are you today? We are as busy as can be. As usual, we are hustling the short people off to the local school houses and preparing for our webinar today on how pharma can manage the unmanageable media with former CNBC reporter and PR man Mike Huckman (see this). So no need for further delay. Here are some tidbits to help us all get started. Have a great day and stay in touch...
Pfizer's Prevnar 13 Wins FDA Panel Backing For Older Adults (Bloomberg News)
J&J Starts Removing Toxins From Baby Products (Associated Press)
Incyte Gets First FDA OK For Rare Blood Cancer Drug (Pharma Times)
UK's NICE Rejects Eisai's Halaven Breast Cancer Med (Pharma Times)
India To End Price Controls For Bulk Drugs (InPharma Technologist)
Lupin Acquires Japanese Injectable Maker (India Info Online)
EDITOR'S NOTE: Please check this post for updates throughout the morning